Energy News / Shareholders Foundation, Inc.

NASDAQ:LOXO Investor Alert: Investigation of Takeover of Loxo Oncology, Inc.

Via: ReleaseWire

Updated 11:00 AM CST, Mon, January 14,2019

An investigation on behalf of investors of Loxo Oncology, Inc. (NASDAQ: LOXO) in connection with the proposed takeover was announced.

San Diego, CA -- (SBWIRE) -- 01/14/2019 -- The takeover of Loxo Oncology, Inc. is under investigation concerning potential breaches of fiduciary duties.

Investors who purchased shares of Loxo Oncology, Inc. (NASDAQ: LOXO) and currently hold any of those NASDAQ: LOXO shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain directors of Loxo Oncology, Inc. breached their fiduciary duties owed to NASDAQ: LOXO investors in connection with the proposed acquisition.

On Jan. 07, 2019, Eli Lilly and Company (NYSE: LLY) and Loxo Oncology, Inc. (NASDAQ: LOXO) announced an agreement for Lilly to acquire Loxo Oncology for $235.00 per share in cash.

However, the investigation concerns whether the offer is unfair to NASDAQ: LOXO stockholders. More specifically, the investigation concerns whether the Loxo Oncology Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.

Shares of Loxo Oncology, Inc. (NASDAQ: LOXO) closed on January 11, 2019, at $232.51 per share.

Those who are current investors in Loxo Oncology, Inc. (NASDAQ: LOXO) shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqloxo-investor-alert-investigation-of-takeover-of-loxo-oncology-inc-1122083.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com